Dr. Samson Gebreab is a lead Program Director for the NIH’s Artificial Intelligence/Machine Learning
Consortium to Advance Health Equity and Researcher Diversity (AIM-AHEAD) program at the Office of
Data Science and Strategy (ODSS). In his role, Dr. Gebreab is responsible for the overall management,
oversight, coordination, and implementation of the AIM-AHEAD program, and for ensuring the benefits
of big data and AI/ML technologies reach across diverse populations.
Previously, Dr. Gebreab served as a Program Director at the NCI Center to Reduce Cancer Health
Disparities (CRHCD) where he managed efforts related to Build Collaborative Partnerships in Cancer
Research and Cancer Health Disparities between Minority Serving Institutions and NCI-Designated
Cancer Centers. Dr. Gebreab also led the management of the Early Investigator Advancement Program
(EIAP), and NCI Research Supplements to Promote Diversity, Reentry, and Re-integration in Cancer
Research Careers. Prior to joining NCI, Dr. Gebreab worked as a Mathematical Statistician at the Center
for Tobacco Products, where he led working groups for sampling design, data analyses, and data delivery
for the PATH Study. Before FDA, Dr. Gebreab was a Staff Scientist at NHGRI where he served as an
Associate Investigator of Genomics, Environmental and Social Determinants of Cardiovascular Disease in
African Americans. He also actively mentored summer students, staff, and postdoctoral fellows. Early in
his career, Dr. Gebreab served as a Biostatistician/Epidemiologist at the Jackson Heart Study.
Dr. Gebreab received his joint M.Sc. and Ph.D. in Statistics and Spatial Epidemiology from Utah State
University. He also received his M.Sc. in Geographic Information Science from Wageningen University,
the Netherlands. Dr. Gebreab completed his postdoctoral training at the University of Michigan School
of Public Health.